Single cell imaging reveals cisplatin regulating interactions between transcription (co)factors and DNA
Open Access
- 25 February 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 12 (15) , 5419-5429
Abstract
Cisplatin is an extremely successful anticancer drug, and is commonly thought to target DNA. However, the way in which cisplatin-induced DNA lesions regulate interactions between transcription factors/cofactors and genomic DNA remains unclear. Herein, we developed a dual-modal microscopy imaging strategy to investigate, in situ, the formation of ternary binding complexes of the transcription cofactor HMGB1 and transcription factor Smad3 with cisplatin crosslinked DNA in single cells. We utilized confocal microscopy imaging to map EYFP-fused HMGB1 and fluorescent dye-stained DNA in single cells, followed by the visualization of cisplatin using high spatial resolution (200–350 nm) time of flight secondary ion mass spectrometry (ToF-SIMS) imaging of the same cells. The superposition of the fluorescence and the mass spectrometry (MS) signals indicate the formation of HMGB1-Pt-DNA ternary complexes in the cells. More significantly, for the first time, similar integrated imaging revealed that the cisplatin lesions at Smad-binding elements, for example GGC(GC)/(CG) and AGAC, disrupted the interactions of Smad3 with DNA, which was evidenced by the remarkable reduction in the expression of Smad-specific luciferase reporters subjected to cisplatin treatment. This finding suggests that Smad3 and its related signalling pathway are most likely involved in the intracellular response to cisplatin induced DNA damage.Keywords
Funding Information
- National Natural Science Foundation of China (21927804, 21575145, 21605146, 21635008, 91543101, 21790390, 21790392, 21505141)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2017051)
- Natural Science Foundation of Beijing Municipality (7182190)
- National Basic Research Program of China (2018YFA0800903)
This publication has 49 references indexed in Scilit:
- Proteomic Strategy for Identification of Proteins Responding to Cisplatin-Damaged DNAAnalytical Chemistry, 2019
- Base‐Resolution Analysis of Cisplatin–DNA Adducts at the Genome ScaleAngewandte Chemie International Edition, 2016
- Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry?Chemical Science, 2012
- DNA interstrand crosslink repair and cancerNature Reviews Cancer, 2011
- The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link RepairScience, 2009
- Direct Cellular Responses to Platinum-Induced DNA DamageChemical Reviews, 2007
- The General Transcription Machinery and General CofactorsCritical Reviews in Biochemistry and Molecular Biology, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Structure, Recognition, and Processing of Cisplatin−DNA AdductsChemical Reviews, 1999
- The HMG-1 box protein family: classification and functional relationshipsNucleic Acids Research, 1995